Dr. Katalin J. Pocsine, MD

Dr. Pocsine practices at Frontier Neurology And Neuromuscular Clinic in Denver, Colorado.

Dr. Pocsine's NPI, 1326138801, was assigned on October 13, 2006. Dr. Pocsine holds Colorado license 45684.

Dr. Pocsine's primary practice is Frontier Neurology and Neuromuscular Clinic, at 3464 S Willow St, Denver, CO 80231. The practice phone is (303) 424-0559.

Dr. Pocsine's primary practice is Frontier Neurology And Neuromuscular Clinic in Denver, Colorado. Dr. Pocsine is also affiliated with Lutheran Hospital. The medical group on file is Frontier Neurology And Neuromuscular Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pocsine practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Pocsine's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Pocsine is licensed in Colorado.

CMS data shows 756 Medicare services from Dr. Pocsine across 10 procedure codes in 2024, for 354 Medicare patients. Medicare paid $87,974 for them. Every service was in an office.

CMS counts 354 Medicare patients who saw Dr. Pocsine in 2024. The largest group is 75 to 84, with 162 patients. 73% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pocsine's median patient age at 69, with 62% women.

In 2024, Dr. Pocsine wrote 1,587 Medicare Part D claims for 341 patients. 87% of them were for generic drugs. CMS names the drug for 1,255 of them, across 35 drugs with 11 or more claims each, at $668,909 in total drug cost. In 2023, CMS named 1,226 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 50 out of 100 for Dr. Pocsine for performance year 2024, reported individually. Dr. Pocsine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pocsine as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,677 general payments to Dr. Pocsine from 88 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Akcea Therapeutics, Inc. paid the most, $7,633.